Fast-Tracking Psychedelics Research – YouTube
Accelerated psychedelics research pathways could significantly impact treatment-resistant psychiatric conditions. This emerging focus highlights the potential for new therapeutic options. Understanding these pathways is crucial for clinicians and…
Huge Study Finds No Evidence Cannabis Helps Anxiety, Depression, or PTSD – PTTC Network
A recent large study on cannabis efficacy mental health conditions found no evidence supporting its benefits for anxiety, depression, or PTSD. This challenges common perceptions and underscores the need for more rigorous research. Clinicians should…
DEA Moves to Allow VA Research Program to Import Marijuana Extract and THC for Clinical Trials
The DEA authorization VA cannabis research marks a pivotal shift enabling clinical trials with standardized marijuana extracts. This federal move supports VA researchers in studying cannabis efficacy for veteran-specific conditions. It promises stronger…
Trump Signs Order to Fast-Track Psychedelic Research | Euronews – CED Clinic
The focus on psychedelic research acceleration aims to speed up evidence generation for psychiatric conditions. This policy shift may influence FDA approval timelines and clinical trial accessibility. It highlights emerging developments in psychedelic…
Joe Rogan Praises Trump’s Executive Order on Psychedelic Research
Psychedelic research funding is crucial for advancing clinical trials and expanding therapeutic options. Trump's executive order aims to accelerate this funding to improve treatment access. This policy shift could significantly impact clinical research…
Podcasters, Presidents, and Psychedelics: How Joe Rogan Got Trump Into Ibogaine
Ibogaine addiction treatment is gaining attention due to emerging psychedelic research and political interest. This article discusses the clinical evidence and safety protocols surrounding ibogaine. Understanding ibogaine's potential and risks is…
President Trump signs executive order encouraging research on psychedelic drugs – WCTV
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Mental HealthPtsdDepressionPolicyResearch…
Trump Accelerates Psychedelic Drug Research to Aid Veterans
Federal policy changes are accelerating psychedelic drug research veterans to improve treatment timelines. This focus on veterans aims to bring MDMA and psilocybin therapies closer to clinical use. The research targets treatment-resistant PTSD and…
Trump Signs Order To Accelerate Legal Access To Psychedelic Therapies For Mental Health
The recent executive order aims to accelerate psychedelic-assisted therapies mental health access, potentially transforming treatment for resistant depression and PTSD. This policy shift could open new pathways for patients who have not responded to…
Largest-Ever Study Finds Medicinal Cannabis Ineffective for Anxiety, Depression, PTSD
A new study reports medicinal cannabis ineffective anxiety depression and PTSD treatment, challenging common perceptions. This finding may influence clinical decision-making and patient counseling. Understanding the study's methodology is crucial before…
